title: Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
abstract: Urocortin (Ucn) is a new member of the corticotropin-releasing factor (CRF) neuropeptide family and has positive inotropic actions and protective effects against ischemia in the rat heart. Ucn binds with very high affinity to both CRF receptor type 1 (CRF-R1) and CRF receptor type 2 (CRF-R2). However, to date, endogenous ligand(s) for CRF receptors expressed in the human heart have yet to be elucidated. In this study, we therefore examined the expression of Ucn and CRF receptors in human heart obtained at autopsy by RT-PCR, immunohistochemistry, and RIA. RT-PCR analysis demonstrated that Ucn and CRF-R2alpha mRNAs were detected in all four chambers. CRF-R1 mRNA was weakly present in some left atria, left ventricles, and in one right ventricle. CRF-R2beta mRNA was detected predominantly in the left atrium. CRF mRNA was not detected in any of the four chambers. Immunostaining for both Ucn and CRF receptors was detected in cardiac myocytes in all four chambers. Ucn-like immunoreactivity was detected in all four chambers by RIA, with the highest concentrations in the left ventricle (1.90 +/- 0.5 pmol/g wet weight, mean +/- SEM; n = 4). On the other hand, CRF-like immunoreactivity was very low or undetectable in the human heart. Sephadex G-50 column chromatography demonstrated that most of the Ucn-like immunoreactivity in the human heart was eluting earlier than the standard Ucn, with one minor peak in the position for Ucn. Ucn immunoreactivity was not detected in skeletal muscle by immunohistochemistry or RIA. These results suggest that Ucn is produced in the human heart and stored there mainly in the larger molecular weight forms. Endogenously produced Ucn may therefore exert its effects mostly through CRF-R2 in an autocrine and/or paracrine manner in the human heart.
authors.affiliation: Department of Pathology, Tohoku University School of Medicine, Sendai, Japan. kimuyu@patholo2.med.tohoku.ac.jp
authors.forename: Yuichiro
authors.initials: Y
authors.lastname: Kimura
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Takahashi
authors.forename: Kazuhito
authors.initials: K
authors.lastname: Totsune
authors.forename: Yasunari
authors.initials: Y
authors.lastname: Muramatsu
authors.forename: Chika
authors.initials: C
authors.lastname: Kaneko
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Darnel
authors.forename: Takashi
authors.initials: T
authors.lastname: Suzuki
authors.forename: Masahito
authors.initials: M
authors.lastname: Ebina
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Nukiwa
authors.forename: Hironobu
authors.initials: H
authors.lastname: Sasano
mesh_terms: D000328:Adult; D000368:Aged; D002845:Chromatography; D003346:Corticotropin-Releasing Hormone / Q000235:genetics / Q000378:metabolism*; D005260:Female; D015870:Gene Expression; D006325:Heart Atria; D006352:Heart Ventricles; D006801:Humans; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D020033:Protein Isoforms / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D011863:Radioimmunoassay; D018019:Receptors, Corticotropin-Releasing Hormone / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014020:Tissue Extracts / Q000032:analysis; D054832:Urocortins; D000099052:CRF Receptor, Type 1
chemical_list: D020033:Protein Isoforms; D012333:RNA, Messenger; D018019:Receptors, Corticotropin-Releasing Hormone; D014020:Tissue Extracts; D054832:Urocortins; D000099052:CRF Receptor, Type 1; D003346:Corticotropin-Releasing Hormone